Tetsuro Oishi

5PUBLICATIONS
28CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 26, 2022
Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.

Tomomi Egawa-Takata, Yutaka Ueda, Kimihiko Ito

|Jan 20, 2022
A simplified procedure of nerve-sparing radical hysterectomy.

Hiroaki Komatsu, Masayo Okawa, Kohei Hikino

|Oct 14, 2021
Differential expression of estrogen receptor subtypes in ovarian high-grade serous carcinoma and clear cell carcinoma.

Daiken Osaku, Tetsuro Oishi, Naoshi Kawamura

|Nov 13, 2020
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial.

Takashi Motohashi, Akira Yabuno, Hiroshi Michimae

|Jun 26, 2019
Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.

Mayumi Sawada, Tetsuro Oishi, Hiroaki Komatsu

Pageof 1

Frequent Collaborators

2 joint publications

Shin Nishio

2 joint publications

Hiroyuki Fujiwara

1 joint publications

Takashi Motohashi

1 joint publications

Akira Yabuno